Intra-Brain and Plasma Levels of L-Serine Are Associated with Cognitive Status in Patients with Chronic Kidney Disease

• Ngā kaituhi matua: Yasunori Iwata (Author), Yusuke Nakade (Author), Masashi Kinoshita (Author), Hemragul Sabit (Author), Riho Nakajima (Author), Kengo Furuichi (Author), Masashi Mita (Author), Maiko Nakane (Author), Norihiko Sakai (Author), Shinji Kitajima (Author), Tadashi Toyama (Author), Taro Miyagawa (Author), Akinori Hara (Author), Miho Shimizu (Author), Kouichi Sato (Author), Megumi Oshima (Author), Shiori Nakagawa (Author), Yuta Yamamura (Author), Hisayuki Ogura (Author), Yoshitaka Koshino (Author), Mitsutoshi Nakada (Author), Takashi Wada (Author)
• Hōputu: Pukapuka
• I whakaputaina: Karger Publishers, 2023-01-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Introduction: The number of patients with chronic kidney disease (CKD) is increasing worldwide. Cognitive impairment is one of the comorbidities of CKD. With the increased number of aged population, novel biomarkers of impaired cognitive function are required. Intra-body profile of amino acid (AA) i...